Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
HYpertension in the Very Elderly Trial
ISRCTN ISRCTN14031168
ClinicalTrials.gov identifier NCT00122811
Public title HYpertension in the Very Elderly Trial
Scientific title
Acronym HYVET
Serial number at source RG/97010
Study hypothesis To assess the benefits of treating very elderly patients with hypertension.
Lay summary
Ethics approval Approved by the relevent central and local ethics committies
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Hypertension
Participants - inclusion criteria 1. People 80 years old and above
2. Sustained systolic pressure 160 - 199 mmHg and diastolic (phase V) pressure 90 - 109 mmHg
3. No evidence of renal failure or co-morbidity requiring anti-hypertensive treatment
Participants - exclusion criteria Does not comply with above inclusion criteria.
Anticipated start date 01/01/2001
Anticipated end date 31/12/2009
Status of trial Completed
Patient information material
Target number of participants 2100
Interventions Two treatment groups:
1. Placebo
2. Indapamide Sustained Release (SR) 1.5 mg plus perindopril 2 - 4 mg if required.

Goal: diastolic blood pressure less than 80 mmHg with systolic pressure less than 150 mmHg.

The patients are followed-up both according to clinical need and every 3 months in the first year and every 6 months thereafter.
Primary outcome measure(s) Stroke events (fatal and non-fatal).
Secondary outcome measure(s) 1. Total mortality
2. Cardiovascular mortality
3. Cardiac mortality
4. Stroke mortality
5. Skeletal fracture
Sources of funding 1. British Heart Foundation (UK) (ref: RG/97010)
2. Institut de Recherches Internationales Servier (France)
Trial website
Publications 1. 2001 main trial protocol in http://www.ncbi.nlm.nih.gov/pubmed/11302283
2. 2006 sub-study protocol in http://www.ncbi.nlm.nih.gov/pubmed/17177983
3. 2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18378519
4. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20497949
Contact name Professor  CJ  Bulpitt
  Address Care of the Elderly
Division of Medicine
ICSM at Hammersmith Hospital
Du Cane Road
  City/town London
  Zip/Postcode W12 0NN
  Country United Kingdom
  Tel +44 (0)20 8383 3959
  Fax +44 (0)20 8743 0798
  Email c.bulpitt@ic.ac.uk
Sponsor British Heart Foundation (UK)
  Address 14 Fitzhardinge Street
  City/town London
  Zip/Postcode W1H 6DH
  Country United Kingdom
  Tel +44 (0)20 7935 0185
  Fax +44 (0)20 7486 5820
  Email research@bhf.org.uk
  Sponsor website: http://www.bhf.org.uk/
Date applied 18/11/2001
Last edited 05/08/2010
Date ISRCTN assigned 18/11/2001
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central